Huang X F, Shelness G S
Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC 27157-1040, USA.
J Lipid Res. 1999 Dec;40(12):2212-22.
The balance between the hepatic assembly of apolipoprotein B (apoB) and its presecretory degradation at the level of the endoplasmic reticulum (ER) may control the secretion of apoB-containing lipoproteins. In one model, apoB that fails to assemble with lipid undergoes translocation arrest, exposing the protein to the cytosolic proteasome. To examine apoB's translocation behavior under various metabolic conditions, glycosylation site utilization studies were performed. A 70-amino acid peptide containing three sites for N-linked glycosylation was appended to the C-terminus of apoB-50 (amino-terminal 50% of apoB) and expressed in both hepatic and nonhepatic cell lines. When the C-terminal reporter peptide was released by cyanogen bromide cleavage, all of the sites were glycosylated irrespective of cell type, labeling time, or assembly status. Similar peptide mapping of endogenous apoB-100 expressed in HepG2 cells was performed to monitor glycosylation at Asn residues 2752 (apoB-61), 2955 (apoB-65), and 3074 (apoB-68). N-linked glycosylation occurred at a minimum of two of the three sites, a frequency identical to that observed in apoB-100 recovered from cell media. Treatment of cells with proteasome inhibitors produced a 2. 5-fold increase in intracellular apoB but failed to cause accumulation of an unglycosylated form. These results indicate that 1) the efficient translocation of apoB into the ER occurs independently of microsomal triglyceride transfer protein and its assembly with lipid and 2) despite its large size and affinity for lipid, delivery of misassembled apoB to the proteasome requires retrograde translocation from the ER lumen to cytosol.
载脂蛋白B(apoB)在肝脏中的组装与其在内质网(ER)水平的分泌前降解之间的平衡可能控制含apoB脂蛋白的分泌。在一种模型中,未能与脂质组装的apoB会发生转运停滞,使该蛋白暴露于胞质蛋白酶体。为了研究apoB在各种代谢条件下的转运行为,进行了糖基化位点利用研究。一个含有三个N-连接糖基化位点的70个氨基酸的肽被附加到apoB-50(apoB的氨基末端50%)的C末端,并在肝细胞系和非肝细胞系中表达。当通过溴化氰切割释放C末端报告肽时,无论细胞类型、标记时间或组装状态如何,所有位点均被糖基化。对在HepG2细胞中表达的内源性apoB-100进行了类似的肽图谱分析,以监测天冬酰胺残基2752(apoB-61)、2955(apoB-65)和3074(apoB-68)处的糖基化。N-连接糖基化至少发生在三个位点中的两个,这一频率与从细胞培养基中回收的apoB-100中观察到的频率相同。用蛋白酶体抑制剂处理细胞会使细胞内apoB增加2.5倍,但未能导致未糖基化形式的积累。这些结果表明:1)apoB向ER的有效转运独立于微粒体甘油三酯转移蛋白及其与脂质的组装;2)尽管apoB体积大且对脂质有亲和力,但将组装错误的apoB递送至蛋白酶体需要从ER腔逆向转运至胞质溶胶。